Biotechnological opportunities in biopharma and firm organization in Argentina

GRACIELA GUTMAN; PABLO LAVARELLO

Buenos Aires

Conferencia; 9th GLOBELICS CONFERENCE: Creativity, Innovation and economic development; 2012

GLOBELICS

In Argentina, some biotechnology firms operating in the human health sector managed to enter into the biosimilars segment of global biopharmaceutical markets at an early stage. These firms’ forms of organization and their articulation with local science and technology infrastructure have played a key role in the development of business strategies in an institutional context that is not conducive to the resolution of the particular risks and uncertainties – be they technological, regulatory, or commercial – associated with these products. This paper examines the strategies of selected firms, using case studies. It advances that group organization and an articulation with public/private networks – which in turn enable the articulation of technological and financial advantages – enables local firms to successfully surmount the obstacles faced by innovative biotechnology firms in peripheral countries.